RxDoctor Payments Data

Franco Alvarez, MD

Psychiatry · West Palm Beach, FLNPI 1629193974

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Axsome Therapeutics, Inc. accounts for 69.4% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for psychiatry clinicians in FL, where the typical reported total is $420.

$356in general payments, 2019–2025

Across 3 payments — averaging $118.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$247
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$109
$150,035in research payments, 2019–2025

Across 2 payments — averaging $75,018 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$147K
  • Pfizer$3K

What the payments were for

  • Food & beverage$356100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$356 in reported general payments places this provider in the 45th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Medicare billing

Part B allowed, 2024
$6,155
Medicare patients
12
Services billed
51

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl41$71,223
TrintellixVortioxetine Hydrobromide45$34,343
RexultiBrexpiprazole12$17,535
Buspirone Hcl331$4,993
Quetiapine Fumarate193$4,939
Atomoxetine Hcl33$4,621
Duloxetine Hcl151$4,153
Aripiprazole129$3,331
Bupropion XlBupropion Hcl151$3,331
Hydroxyzine Pamoate193$3,130
Trazodone Hcl303$2,354
Oxcarbazepine45$2,139
Divalproex Sodium58$1,668
Venlafaxine Hcl ErVenlafaxine Hcl89$1,571
Bupropion Hcl SrBupropion Hcl88$1,502

Paid to pharmacies, not to this prescriber.

Other psychiatry in West Palm Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →